Medical Intelligence Quiz

Challenge Yourself, Build Your Knowledge

ACC Recommendations: Non-statin lowering of LDL-C in ASCVD

Question 1 of 5

According to the American College of Cardiology (ACC), in adult patients aged 21 years or older who have clinical atherosclerotic cardiovascular disease (ASCVD), with comorbidities and baseline low-density lipoprotein cholesterol (LDL-C) 70 to 189 mg/dL, and who are already taking maximally tolerated statin therapy for secondary prevention, the addition of __________ may be considered for further reducing LDL-C.